101 related articles for article (PubMed ID: 15942646)
41. Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Qian F; Engst S; Yamaguchi K; Yu P; Won KA; Mock L; Lou T; Tan J; Li C; Tam D; Lougheed J; Yakes FM; Bentzien F; Xu W; Zaks T; Wooster R; Greshock J; Joly AH
Cancer Res; 2009 Oct; 69(20):8009-16. PubMed ID: 19808973
[TBL] [Abstract][Full Text] [Related]
42. [Effect of hepatocyte growth factor on invasion of ovarian cancer cell line SKOV3 and its signal transduction pathway].
Wang HL; Zhang SL; Lu YM; Jiang JY; Zhu XY
Ai Zheng; 2006 May; 25(5):570-5. PubMed ID: 16687076
[TBL] [Abstract][Full Text] [Related]
43. Lipopolysaccharide potentiates the effect of hepatocyte growth factor upon replication in lung, thyroid, spleen, and colon in rats in vivo.
Gao C; Kennedy S; Ponder KP
Mol Ther; 2001 Apr; 3(4):462-75. PubMed ID: 11319906
[TBL] [Abstract][Full Text] [Related]
44. [Effects of hepatocyte growth factor gene transfection on adriamycin-induced apoptosis of gastric cancer cells in vitro].
Shen JG; Cheong JH; Noh SH; Wang LB
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):338-41. PubMed ID: 17892127
[TBL] [Abstract][Full Text] [Related]
45. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J
J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638
[TBL] [Abstract][Full Text] [Related]
46. Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease.
Yoshida Y; Hirano T; Son G; Iimuro Y; Imado T; Iwasaki T; Fujimoto J
Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1114-23. PubMed ID: 17761834
[TBL] [Abstract][Full Text] [Related]
47. Hepatocyte growth factor induces anoikis resistance by up-regulation of cyclooxygenase-2 expression in uterine endometrial cancer cells.
Kanayama S; Yamada Y; Kawaguchi R; Tsuji Y; Haruta S; Kobayashi H
Oncol Rep; 2008 Jan; 19(1):117-22. PubMed ID: 18097584
[TBL] [Abstract][Full Text] [Related]
48. Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer.
Seiden-Long IM; Brown KR; Shih W; Wigle DA; Radulovich N; Jurisica I; Tsao MS
Oncogene; 2006 Jan; 25(1):91-102. PubMed ID: 16158056
[TBL] [Abstract][Full Text] [Related]
49. Up-regulation of p21CIP1 expression mediated by ERK-dependent and -independent pathways contributes to hepatocyte growth factor-induced inhibition of HepG2 hepatoma cell proliferation.
Shirako E; Hirayama N; Tsukada Y; Tanaka T; Kitamura N
J Cell Biochem; 2008 May; 104(1):176-88. PubMed ID: 18004740
[TBL] [Abstract][Full Text] [Related]
50. Hepatocyte growth factor-modulated rat Leydig cell functions.
Del Bravo J; Catizone A; Ricci G; Galdieri M
J Androl; 2007; 28(6):866-74. PubMed ID: 17609297
[TBL] [Abstract][Full Text] [Related]
51. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
52. Endogenous hepatocyte growth factor is a niche signal for subventricular zone neural stem cell amplification and self-renewal.
Nicoleau C; Benzakour O; Agasse F; Thiriet N; Petit J; Prestoz L; Roger M; Jaber M; Coronas V
Stem Cells; 2009 Feb; 27(2):408-19. PubMed ID: 18988709
[TBL] [Abstract][Full Text] [Related]
53. Expression of hepatocyte growth factor and c-Met after spinal cord injury in rats.
Shimamura M; Sato N; Sata M; Wakayama K; Ogihara T; Morishita R
Brain Res; 2007 Jun; 1151():188-94. PubMed ID: 17425951
[TBL] [Abstract][Full Text] [Related]
54. Hepatocyte growth factor promotes endogenous repair and functional recovery after spinal cord injury.
Kitamura K; Iwanami A; Nakamura M; Yamane J; Watanabe K; Suzuki Y; Miyazawa D; Shibata S; Funakoshi H; Miyatake S; Coffin RS; Nakamura T; Toyama Y; Okano H
J Neurosci Res; 2007 Aug; 85(11):2332-42. PubMed ID: 17549731
[TBL] [Abstract][Full Text] [Related]
55. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
[TBL] [Abstract][Full Text] [Related]
56. [Sustaining effect of gene-transferring hepatic stellate cell strain CFSC/HGF on hepatocytes development].
Wang YF; Nan X; Li YH; Zhang R; Yue W; Yan F; Pei XT
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):45-8. PubMed ID: 15670492
[TBL] [Abstract][Full Text] [Related]
57. Therapeutic effect of adenoviral-mediated hepatocyte growth factor gene administration on TNBS-induced colitis in mice.
Mukoyama T; Kanbe T; Murai R; Murawaki Y; Shimomura T; Hashiguchi K; Saeki T; Ichiba M; Yoshida Y; Tanabe N; Kurimasa A; Harada K; Yashima K; Hisatome I; Ito H; Murawaki Y; Shiota G
Biochem Biophys Res Commun; 2005 Apr; 329(4):1217-24. PubMed ID: 15766556
[TBL] [Abstract][Full Text] [Related]
58. Hepatocyte growth factor protects hepatoblastoma cells from chemotherapy-induced apoptosis by AKT activation.
Grotegut S; Kappler R; Tarimoradi S; Lehembre F; Christofori G; Von Schweinitz D
Int J Oncol; 2010 May; 36(5):1261-7. PubMed ID: 20372801
[TBL] [Abstract][Full Text] [Related]
59. Adenovirus-mediated hepatocyte growth factor gene transfer prevents lethal liver failure in rats.
Nomi T; Shiota G; Isono M; Sato K; Kawasaki H
Biochem Biophys Res Commun; 2000 Nov; 278(2):338-43. PubMed ID: 11097840
[TBL] [Abstract][Full Text] [Related]
60. Gene therapy eradicating distant disseminated micro-metastases by optimal cytokine expression in the primary lesion only: novel concepts for successful cytokine gene therapy.
Nagano S; Yuge K; Fukunaga M; Terazaki Y; Fujiwara H; Komiya S; Kosai K
Int J Oncol; 2004 Mar; 24(3):549-58. PubMed ID: 14767539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
